Table 3.

Results of univariate and multivariate analyses on potential prognostic factors affecting local tumor recurrence after superselective transarterial chemoembolization

Factors	Univariate		Multivariate
	OR (95% CI)	P-value	OR (95% CI)	P-value
Alpha fetoprotein (≤200 vs. >200 ng/mL)	0.39 (0.19–0.78)	0.010*
Total bilirubin (≤1.5 vs. >1.5 mg/dL)	0.43 (0.19–0.99)	0.068
Portal hypertension (No vs. Yes)	0.60 (0.28–1.29)	0.179
Tumor size (≤30 vs. >30 mm)	0.47 (0.23–0.96)	0.045*
Iodized oil deposition with SM (gr A vs. B/C)	0.15 (0.06–0.34)	<0.001*	0.16 (0.07–0.39)	<0.001*
PV visualization (Prominent/mild vs. None)	0.39 (0.19–0.79)	0.014*	0.40 (0.18–0.88)	0.029*
Dose of doxorubicin (≤20 vs. >20 mg)	0.48 (0.24–1.00)	0.061
Dose of lipiodol (≤8 vs. >8 mL)	0.49 (0.23–1.03)	0.073

OR, odds ratio; CI, confidence interval; SM, safety margin; gr, grade; PV, portal vein.

^*Likelihood ratio test.